Effectiveness of Trushna Shamak Yavagu in Breast cancer patients to reduce the side effects of Chemotherapy

An open labeled randomised controlled clinical study to assess the efficacy of Trushna Shamak Yavagu in the alleviation of chemotherapy induced side effects in Breast cancer patients.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/081408

Enrollment

Registered

2025-02-27

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C50- Malignant neoplasm of breast

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Diagnosed carcinoma (breast) patients on chemotherapy 2.Age 18 to 60 years of females 3.Patients with mild to moderate side effects 4.Controlled Diabetes Mellitus & Hypertension

Exclusion criteria

Exclusion criteria: 1.Cycle 01 of Chemotherapy 2.With severe cases of side effects 3.Uncontrolled Diabetes Mellitus & Hypertension, Pregnant and Lactating women, With contagious diseases such as TB or Hepatitis C

Design outcomes

Primary

Measure	Time frame
Improvement on MSAS scaleTimepoint: every 7 days for 63 days	—

Secondary

Measure	Time frame
Any effect on Quality of lifeTimepoint: every 30 days till 63 days	—

Countries

India

Contacts

Public ContactDr Vinay Pawar

D.Y.Patil School of Ayurveda

vinay.pawar@dypatil.edu7506631982

Outcome results